BIO CEO Jim Greenwood: An Interview With “The Pink Sheet” Daily (Part 3 of 3)
This article was originally published in The Pink Sheet Daily
Executive Summary
The pharma and tech sectors remain divided on patent reform, but the head of the Biotechnology Industry Organization has an idea for a compromise.
You may also be interested in...
BIO CEO Jim Greenwood: An Interview with “The Pink Sheet” Daily (Part 2)
The head of the Biotechnology Industry Organization says what he’d like to see in the next HHS administrator, and how the Obama administration should think about health care reform.
BIO CEO Jim Greenwood: An Interview With “The Pink Sheet” Daily (Part 1 of 3)
The head of the Biotechnology Industry Organization describes the “dire circumstances” of many of its members, and industry’s proposal to include biotech in the economic stimulus package.
Companies Reveal Hurdles In Providing Drugs Via Expanded Access Programs
GSK, Stealth BioTherapeutics and Blueprint Medicines discuss the difficulties getting participation of physicians, the excessive cost of expanded access, and whether physicians should report research data.